NovoCure Limited (NVCR)
NASDAQ: NVCR
· Real-Time Price · USD
17.30
0.30 (1.76%)
At close: Jun 25, 2025, 3:59 PM
17.32
0.14%
After-hours: Jun 25, 2025, 06:13 PM EDT
1.76% (1D)
Bid | 16.25 |
Market Cap | 1.93B |
Revenue (ttm) | 621.71M |
Net Income (ttm) | -164.19M |
EPS (ttm) | -1.51 |
PE Ratio (ttm) | -11.46 |
Forward PE | -9.71 |
Analyst | Buy |
Ask | 17.6 |
Volume | 1,249,181 |
Avg. Volume (20D) | 1,137,051 |
Open | 17.06 |
Previous Close | 17.00 |
Day's Range | 16.77 - 17.33 |
52-Week Range | 14.17 - 34.13 |
Beta | 0.75 |
About NVCR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVCR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NVCR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
NovoCure Limited is scheduled to release its earnings on Jul 24, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-10.83%
NovoCure shares are trading lower after the compan...
Unlock content with
Pro Subscription
3 months ago
-12.43%
NovoCure shares are trading lower after the company reported a Q4 Gaap EPS miss.